ETAR Blockade’s Role in Current and Emerging Therapies for IgAN– Explore the Visual Abstract
This visual abstract was supported by an unrestricted educational grant from Chinook Therapeutics, a Novartis Company.
“International Comparison, East vs. West”: The ISN-JSN-APSN Joint Session at the 17th International Symposium on IgA Nephropathy
The latest findings on the pathogenesis and treatment of IgAN will be presented and discussed at the 17th International Symposium on IgA Nephropathy in Tokyo, Japan, from September 27-30, 2023. The ISN, the Japanese Society of Nephrology (JSN), and the Asian Pacific Society of Nephrology (APSN) will hold a joint session, "International Comparison, East...